Knight Therapeutics Announces Closing of Previously Announced Acquisition and Exclusive License to Exelon® in Canada and Latin America Medical Device Investing
Myovant Sciences and Pfizer Receive FDA Approval for MYFEMBREE®, the First Once-Daily Treatment for Heavy Menstrual Bleeding Associated With Uterine Fibroids Pharmaceutical Investing
AbbVie to Present Data from its Leading Migraine Portfolio at the 2021 American Headache Society Annual Scientific Meeting Biotech Investing
Bristol Myers Squibb to Take Part in Bernstein's 37th Annual Strategic Decisions Conference Biotech Investing
Satcher Health Leadership Institute At Morehouse School Of Medicine, With Support From Google.org And Gilead Sciences, Launches Health Equity Tracker To Study Racial Health Inequities Related To Covid-19 Biotech Investing
Xencor and Bristol Myers Squibb Enter License Agreement for Use of Xtend XmAb® Technology in SARS-CoV-2 Neutralizing Monoclonal Antibody Combination for the Treatment of COVID-19 Biotech Investing
